HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lipoxin B4

structure in first source
Also Known As:
5,14,15-THET; 5,14,15-trihydroxy-6,8,10,12-eicosatetraenoic acid; 5-methyl-LXB4; 5D,14,15L-trihydroxy-6,8,10,12-eicosatetraenoic acid; LXB4; 6,8,10,12-Eicosatetraenoic acid, 5,14,15-trihydroxy-, (SP-4-2)-
Networked: 23 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Dalli, Jesmond: 3 articles (01/2022 - 01/2017)
2. Livne-Bar, Izhar: 2 articles (06/2022 - 12/2017)
3. Sivak, Jeremy M: 2 articles (06/2022 - 12/2017)
4. Norris, Paul C: 2 articles (01/2020 - 01/2017)
5. Serhan, Charles N: 2 articles (01/2020 - 01/2017)
6. Shinohara, Masakazu: 2 articles (01/2020 - 01/2017)
7. Colas, Romain A: 2 articles (11/2019 - 01/2017)
8. Autelitano, François: 1 article (06/2022)
9. Boldron, Christophe: 1 article (06/2022)
10. Brown, Carla E: 1 article (06/2022)

Related Diseases

1. Ocular Hypertension (Glaucoma, Suspect)
2. Inflammation (Inflammations)
3. Asthma (Bronchial Asthma)
4. Sepsis (Septicemia)
5. Nasal Polyps (Nasal Polyp)

Related Drugs and Biologics

1. Cytokines
2. Autacoids
3. lipoxin A4
4. lipoxin B4
5. Lipoxins
6. Lipids
7. Interleukin-10 (Interleukin 10)
8. Interleukin-6 (Interleukin 6)
9. Interleukin-4 (Interleukin 4)
10. Dinoprostone (PGE2)

Related Therapies and Procedures

1. Therapeutics